Transabdominal chorionic villus sampling in a multiple pregnancy at risk of argininosuccinic aciduria: A case report

1990 ◽  
Vol 36 (4) ◽  
pp. 449-450 ◽  
Author(s):  
Leen Pijpers ◽  
Wim J. Kleijer ◽  
Annette Reuss ◽  
Milena G. J. Jahoda ◽  
Frans J. Los ◽  
...  
PEDIATRICS ◽  
1985 ◽  
Vol 76 (5) ◽  
pp. 794-800
Author(s):  
Arleen D. Auerbach ◽  
Michal Sagi ◽  
Barbara Adler

We report our experience, since 1978, with prenatal diagnosis in fetuses at risk for Fanconi anemia. Amniotic fluid cells from 30 fetuses from 24 families were monitored for baseline and diepoxybutane-induced chromosomal breakage. Seven of the fetuses at risk were diagnosed as affected; baseline and diepoxybutane-induced breakage ranged from 0.18 to 0.45 and 0.69 to 0.96 breaks per cell, respectively. The range of baseline and diepoxybutane-induced chromosomal breakage in amniocytes from the 23 pregnancies at risk that were diagnosed prenatally as unaffected ranged from 0 to 0.08 and 0 to 0.13 breaks per cell, respectively. Four of these cases were also diagnosed as normal on the basis of chromosomal breakage studies in cells obtained by chorionic villus sampling. The range of baseline and diepoxybutane-induced breakage in cells from five control fetuses was 0 to 0.05 and 0 to 0.10 breaks per cell, respectively. Of the pregnancies diagnosed as affected, two were carried to term, whereas five were terminated. One newborn and two abortuses had congenital malformations including abnormalities of the thumb and radius. The other affected live-born infant, now 5½ years old, has severe growth retardation and pancytopenia. No Fanconi anemia-associated malformations were found in any of the other fetuses or newborns studied. In all cases in which tissue was available for study, diagnoses were confirmed by chromosome breakage studies. This method thus permits reliable detection of Fanconi anemia.


2001 ◽  
Vol 21 (13) ◽  
pp. 1111-1113 ◽  
Author(s):  
Nancy Steinberg Warren ◽  
Shirley Soukup ◽  
Jennifer L. King ◽  
Peter St. J. Dignan

1987 ◽  
Vol 156 (4) ◽  
pp. 912-914 ◽  
Author(s):  
Giovanni Monni ◽  
Rosa Maria Ibba ◽  
Giovanni Olla ◽  
Cristina Rosatelli ◽  
Antonio Cao

1994 ◽  
Vol 14 (6) ◽  
pp. 451-454 ◽  
Author(s):  
Jana Klein ◽  
John M. Graham ◽  
Lawrence D. Platt ◽  
Rhona Schreck

Author(s):  
O.V. Pribushenya

Retrospective assessment of the obstetric and gynecological history, gravidity, parity and complications of the current pregnancy in women who underwent amniocentesis (AC) and chorionic villus sampling (CVS) are presented. The features of invasive prenatal procedures (IPP), as well as the outcomes of pregnancy and childbirth were studied. The frequency of spontaneous abortion (SA) after AC was 2.90 ± 2.05%, during CVS — 2.80 ± 2.82%, in the comparison group (GC) (1.10 ± 1.07%, p > 0.017). There were no statistically significant differences in invasive prenatal diagnostics in the 1st and 2nd trimesters in multiple and single pregnancies. AC and CVS do not affect the average delivery time (CVS — 37.0 (34.0–38.0) weeks, AC — 36.0 (34.0–38.0) weeks, GS — 36.0 (34.0–37.0) weeks, p > 0.017), weight of newborns (CVH — 2440.0 (1960.0–2845.0) g, AC — 2600.0 (1850.0–2760.0) g, GS — 2325.0 (1800.0–2740.0) g, p > 0.017). IPP do not increase the preterm birth rate at 23–36 weeks' gestation (CVH — 41.40 ± 9.15%, AC — 51.60 ± 6.36%, GS — 54.40 ± 5.19%, p > 0.017) and does not increase perinatal mortality.


2021 ◽  
Vol 9 (12) ◽  
pp. 734-738
Author(s):  
Dieuwertje Horsten ◽  
Lore Noben ◽  
Laura van Dommelen ◽  
Carolien A.M. Koks

Author(s):  
Varsha P. Sorathiya ◽  
Roshan B. Colah ◽  
Nishith A. Vachhani ◽  
Sanjeev L. Nandani ◽  
Daya J. Vekariya ◽  
...  

Background: Hemoglobinopathies pose a significant health burden in the Saurashtra region in western India. Identifying couples at- risk of having a child with a severe hemoglobin disorder prenatally can help in counseling with the option of prenatal diagnosis.Methods: All pregnant carriers of β thalassemia were advised to screen their husbands. If both were carriers, they were counselled to undergo prenatal diagnosis. Prenatal diagnosis was done in 174 couples. Chorionic villus sampling was done at 10 to 12 weeks gestation and the tissue sample was sent to the Genetic laboratory for DNA analysis along with blood samples of the parents. If the couple came after 14 weeks of pregnancy, amniocentesis was done and amniotic fluid was sent for DNA analysis. If the fetus was affected, the option of termination of the pregnancy was given.Results: In 50.5% of couples, the fetus was a carrier of β thalassemia, in 1.7% the fetus had hemoglobin E trait and in 23.0% the fetus was normal.  In 20.6% of couples, the fetus had β Thalassaemia major and after counseling, these couples opted for termination. 1.2% of couples had a fetus which was unaffected but remained in distinguished (normal/thalassemia carrier) while in 0.6% of cases the fetus had sickle-β thalassemia. In 1.2% of cases the result was inconclusive. In 1.2% of cases the results were not available for lack of follow up.Conclusions: Screening antenatal women for identifying carriers and referring couples at-risk for prenatal diagnosis helped in preventing the birth of 36 thalassemia major children.


Sign in / Sign up

Export Citation Format

Share Document